Eli Lilly and Novo Nordisk, which already have approved GLP-1 weight loss drugs that are raking in billions of revenues, have ...

Discover why Novo Nordisk's current sell-off offers a strong buy opportunity. Backed by solid fundamentals, growth prospects, ...

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

DexCom has significant room to grow in its core market, despite disappointing results last year. One of Warren Buffett's ...

Novo Nordisk (NVO) reached $69.82 at the closing of the latest trading day, reflecting a +1.16% change compared to its last close.

Hims & Hers Health (HIMS -3.91%) is a telehealth company that offers personalized solutions for its customers. And demand has ...

Investing.com -- Italian authorities appointed a special commissioner on Monday to help Novo Nordisk (NYSE: NVO) deliver its planned €2 billion ($2.34 billion) investment in a factory near Rome.

COPENHAGEN (Reuters) -Novo Nordisk’s top executives ignored internal warnings that the company was not sufficiently prepared ...

Hims & Hers stands out for personalized, compounded medications and consistent margin expansion but faces rising risks tied ...

Spain is investigating Novo Nordisk over concerns it may be illegally advertising its weight loss drugs Ozempic and Wegovy ...

Novo Nordisk NVO has experienced remarkable growth in recent years, largely fueled by the commercial success of its ...